Lv1
50 积分 2025-11-02 加入
The Diversity of Gut Microbiome is Associated With Favorable Responses to Anti–Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC
3个月前
已完结
Combined systemic treatments in two patients with ductal salivary carcinoma
3个月前
已关闭
Complete response with trastuzumab in heavily pretreated HER2-positive metastatic salivary duct carcinoma
3个月前
已完结
HER2 inhibitor-based combination therapy for recurrent and metastatic salivary duct carcinoma in an elderly patient: a case report and literature review
4个月前
已完结
Case report: ado-trastuzumab as second-line treatment in HER2 positive salivary duct carcinoma
4个月前
已完结
Salivary duct carcinoma responding to trastuzumab‐based therapy: Case report and review of the literature
4个月前
已关闭
Case report: ado-trastuzumab as second-line treatment in HER2 positive salivary duct carcinoma
4个月前
已关闭
Combined androgen deprivation therapy in recurrent androgen-receptor-positive salivary duct carcinoma – a case report and review of the literature
4个月前
已完结
Clinical trial of nintedanib in patients with recurrent or metastatic salivary gland cancer of the head and neck: A multicenter phase 2 study (Korean Cancer Study Group HN14‐01)
4个月前
已完结
LBA36 A randomised phase II study to evaluate the efficacy and safety of androgen deprivation therapy (ADT) vs chemotherapy (CT) in patients with recurrent and/ or metastatic, androgen receptor (AR) expressing, salivary gland cancers
4个月前
已完结
皖公网安备34019202002308
